Back to search

Article

Trastuzumab in combination with capecitabine plus cisplatin for the treatment of advanced HER2-positive gastric cancer: A systematic review and meta-analysis

2023-08-18

Abstract excerpt

<title>Abstract</title> <p><bold>AIM</bold> The primary objective of this study was to comprehensively evaluate and compare the therapeutic efficacy of trastuzumab in combination with capecitabine plus cisplatin versus capecitabine plus cisplatin in the management of patients diagnosed with advanced human epidermal growth factor receptor 2 (HER2)-positive gastric cancer. By generating robust evidence-based medica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3812db4-ab11-545d-a389-17d356586db8
DOI
10.21203/rs.3.rs-3261138/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Trastuzumab in combination with capecitabine plus cisplatin for the treatment of advanced HER2-positive gastric cancer: A systematic review and meta-analysisDOI 10.21203/rs.3.rs-3261138/v1
Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.Semantic proximity
Development and Validation of a General Clinical Model for Predicting Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer: Evidence from Meta-Analysis and Real-World StudySemantic proximity
Comparison of Targeted Therapy Efficacy in HER2-Positive Versus HER2-Negative Breast Cancer PatientsSemantic proximity
First-line pembrolizumab, trastuzumab, and chemotherapy in advanced HER2-positive gastric cancer with sequential genomic profilingSemantic proximity
The genomics and therapeutics of HER2-positive gastric cancer—from trastuzumab and beyondSemantic proximity
Complete Remission of a Patient With HER-2 amplification Gastric Cancer Treated With Sintilimab Combined With TrastuzumabSemantic proximity
Advanced gastric cancer: Current treatment landscape and future perspectives.Semantic proximity
Genomic correlations for clinical outcomes in HER2-positive advanced gastric cancers treated using trastuzumab-based therapySemantic proximity
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.Semantic proximity
The Efficacy and Safety of Sacituzumab Govitecan in Heavily Pretreated Metastatic Triple-Negative and Hormone Receptor-Positive/HER2-Negative Breast Cancer: A Multicenter Real-World Study from TurkeySemantic proximity
PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.Semantic proximity
Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.Semantic proximity
Select a neighboring publication to make it the new centre.